ArticleSurgery2012

Pasireotide (SOM230) is effective for the treatment of pancreatic neuroendocrine tumors (PNETs) in a multiple endocrine neoplasia type 1 (MEN1) conditional knockout mouse model.

Thomas J Quinn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.